Cargando…

Blood pressure and mortality in patients with type 2 diabetes and a recent coronary event in the ELIXA trial

BACKGROUND: The relationship between blood pressure and mortality in type 2 diabetes (T2DM) is controversial, with concern for increased risk associated with excessively lowered blood pressure. METHODS: We evaluated whether prior cardiovascular disease (CVD) altered the relationship between baseline...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wijkman, Magnus O., Claggett, Brian, Diaz, Rafael, Gerstein, Hertzel C., Køber, Lars, Lewis, Eldrin, Maggioni, Aldo P., Wolsk, Emil, Aguilar, David, Bentley-Lewis, Rhonda, McMurray, John J., Probstfield, Jeffrey, Riddle, Matthew, Tardif, Jean-Claude, Solomon, Scott D., Pfeffer, Marc A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7552471/ https://www.ncbi.nlm.nih.gov/pubmed/33046070 http://dx.doi.org/10.1186/s12933-020-01150-0

Ejemplares similares

Retinopathy, Neuropathy, and Subsequent Cardiovascular Events in Patients with Type 2 Diabetes and Acute Coronary Syndrome in the ELIXA: The Importance of Disease Duration
por: Seferovic, Jelena P., et al.
Publicado: (2018)

Risk Estimates of Imminent Cardiovascular Death and Heart Failure Hospitalization Are Improved Using Serial Natriuretic Peptide Measurements in Patients With Coronary Artery Disease and Type 2 Diabetes
por: Wolsk, Emil, et al.
Publicado: (2022)

Role of B‐Type Natriuretic Peptide and N‐Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus
por: Wolsk, Emil, et al.
Publicado: (2017)

NT‐proBNP by Itself Predicts Death and Cardiovascular Events in High‐Risk Patients With Type 2 Diabetes Mellitus
por: Malachias, Marcus V. B., et al.
Publicado: (2020)

Coronary Artery Disease Is a Predictor of Progression to Dialysis in Patients With Chronic Kidney Disease, Type 2 Diabetes Mellitus, and Anemia: An Analysis of the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)
por: Sabe, Marwa A., et al.
Publicado: (2016)

Response to Comment on: The ORIGIN Trial Investigators. Characteristics Associated With Maintenance of Mean A1C <6.5% in People With Dysglycemia in the ORIGIN Trial. Diabetes Care 2013;36:2915–2922
por: Riddle, Matthew C., et al.
Publicado: (2013)

Sex Differences in Clinical Characteristics and Outcomes After Myocardial Infarction With Low Ejection Fraction: Insights From PARADISE‐MI
por: Wang, Xiaowen, et al.
Publicado: (2023)

Effects of sacubitril/valsartan on glycemia in patients with diabetes and heart failure: the PARAGON-HF and PARADIGM-HF trials
por: Wijkman, Magnus O., et al.
Publicado: (2022)

Sex differences in congestive markers in patients hospitalized for acute heart failure
por: Espersen, Caroline, et al.
Publicado: (2021)

Relationship Between A1C and Fasting Plasma Glucose in Dysglycemia or Type 2 Diabetes: An analysis of baseline data from the ORIGIN trial
por: Ramachandran, Ambady, et al.
Publicado: (2012)

Body mass index and B‐lines on lung ultrasonography in chronic and acute heart failure
por: Brainin, Philip, et al.
Publicado: (2020)

Predictors of Development of Diabetes in Patients With Chronic Heart Failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) Program
por: Preiss, David, et al.
Publicado: (2009)

Left atrial inflow propagation velocity derived by color M-mode Doppler in acute heart failure
por: Johannessen, Øyvind, et al.
Publicado: (2022)

Longitudinal trajectories in renal function before and after heart failure hospitalization among patients with heart failure with preserved ejection fraction in the PARAGON‐HF trial
por: Chatur, Safia, et al.
Publicado: (2022)

Sacubitril–valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fraction
por: Jackson, Alice M, et al.
Publicado: (2021)

Sacubitril/valsartan and loop diuretic requirement in heart failure with preserved ejection fraction in the PARAGON‐HF trial
por: Chatur, Safia, et al.
Publicado: (2022)

Resistance to antihypertensive treatment and long‐term risk: The Atherosclerosis Risk in Communities study
por: Wijkman, Magnus O., et al.
Publicado: (2021)

Efficacy and safety outcomes of dulaglutide by baseline HbA1c: A post hoc analysis of the REWIND trial
por: Franek, Edward, et al.
Publicado: (2022)

IMPROVE-IT: A Final Closure to Carcinogenicity of Ezetimibe?
por: Lewis, Eldrin F., et al.
Publicado: (2020)

Impact of Chronic Obstructive Pulmonary Disease in Patients With Heart Failure With Preserved Ejection Fraction: Insights From PARAGON‐HF
por: Mooney, Leanne, et al.
Publicado: (2021)

Risk factors, mortality trends and cardiovasuclar diseases in people with Type 1 diabetes and controls: A Swedish observational cohort study
por: Hallström, Sara, et al.
Publicado: (2022)

Are U‐shaped relationships between risk factors and outcomes artifactual?
por: Shah, Reema, et al.
Publicado: (2022)

Pharmacogenetics-guided dalcetrapib therapy after an acute coronary syndrome: the dal-GenE trial( )
por: Tardif, Jean Claude, et al.
Publicado: (2022)

Within trial comparison of survival time projections from short‐term follow‐up with long‐term follow‐up findings
por: Ferreira, João Pedro, et al.
Publicado: (2022)

Creating Composite Indices From Continuous Variables for Research: The Geometric Mean
por: Gerstein, Hertzel C., et al.
Publicado: (2021)

Prevalence of Prediabetes and Undiagnosed Diabetes in Patients with HFpEF and HFrEF and Associated Clinical Outcomes
por: Kristensen, Søren L., et al.
Publicado: (2017)

A novel kidney disease index reflecting both the albumin-to-creatinine ratio and estimated glomerular filtration rate, predicted cardiovascular and kidney outcomes in type 2 diabetes
por: Gerstein, Hertzel C., et al.
Publicado: (2022)

Flu Vaccine and Mortality in Hypertension: A Nationwide Cohort Study
por: Modin, Daniel, et al.
Publicado: (2022)

Effects of sacubitril/valsartan versus valsartan on renal function in patients with and without diabetes and heart failure with preserved ejection fraction: insights from PARAGON‐HF
por: Peikert, Alexander, et al.
Publicado: (2022)

Long-Term Consequences of Fetal and Neonatal Nicotine Exposure: A Critical Review
por: Bruin, Jennifer E., et al.
Publicado: (2010)

Exploring potential mediators of the cardiovascular benefit of dulaglutide in type 2 diabetes patients in REWIND
por: Konig, Manige, et al.
Publicado: (2021)

Effects of In-Bed Cycle Exercise in Patients With Acute Stroke: A Randomized Controlled Trial
por: Sandberg, Klas, et al.
Publicado: (2020)

Hemodynamic responses to In‐Bed Cycle Exercise in the acute phase after moderate to severe stroke: A randomized controlled trial
por: Sandberg, Klas, et al.
Publicado: (2021)

Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19
por: Vaduganathan, Muthiah, et al.
Publicado: (2020)

Generalizability of glucagon‐like peptide‐1 receptor agonist cardiovascular outcome trials to the overall type 2 diabetes population in the United States
por: Boye, Kristina S., et al.
Publicado: (2019)

Effect of sacubitril/valsartan on recurrent events in the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM‐HF)
por: Mogensen, Ulrik M., et al.
Publicado: (2018)

Development and external validation of prognostic models to predict sudden and pump-failure death in patients with HFrEF from PARADIGM-HF and ATMOSPHERE
por: Shen, Li, et al.
Publicado: (2021)

Accumulation of Deficits as a Key Risk Factor for Cardiovascular Morbidity and Mortality: A Pooled Analysis of 154 000 Individuals
por: Farooqi, Mohammed A. M., et al.
Publicado: (2020)

Optimizing Health Coaching for Patients With Type 2 Diabetes Using Machine Learning: Model Development and Validation Study
por: Di, Shuang, et al.
Publicado: (2022)

Uric acid in advanced heart failure: relation to central haemodynamics and outcome
por: Deis, Tania, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4bgqdrid55dp86on2kpna20lal